share_log

FY2022 EPS Estimates for Canada Nickel Company Inc. Lowered by Analyst (CVE:CNC)

Financial News Live ·  Jul 12, 2022 01:42

Canada Nickel Company Inc. (CVE:CNC – Get Rating) – Equities researchers at Cormark cut their FY2022 earnings per share (EPS) estimates for shares of Canada Nickel in a report released on Thursday, July 7th. Cormark analyst S. Ioannou now anticipates that the company will post earnings of ($0.03) per share for the year, down from their previous forecast of ($0.01). The consensus estimate for Canada Nickel's current full-year earnings is ($0.03) per share.

Get Canada Nickel alerts:

Shares of Canada Nickel stock opened at C$1.81 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.85 and a quick ratio of 1.83. Canada Nickel has a 1 year low of C$1.41 and a 1 year high of C$4.01. The company has a market capitalization of C$204.14 million and a P/E ratio of -23.82. The business has a 50 day moving average price of C$1.87 and a 200 day moving average price of C$2.61.

About Canada Nickel (Get Rating)

Canada Nickel Company Inc explores and discovers nickel sulphide assets. Its flagship property is the 100% owned Crawford Nickel-Cobalt Sulphide Project located in northern Ontario, Canada. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

Further Reading

  • Can Tesla's Stock Survive the Onslaught of Competition?
  • Five Below Stock is a Recession Play
  • Here's How to Dollar Cost Average into Positions in a Bear Market
  • MarketBeat: Week in Review 7/4 – 7/8
  • AT&T (NYSE:T) Is Its Cheaper Valuation Worth A Buy?

Receive News & Ratings for Canada Nickel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canada Nickel and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment